CMS Turns to 'Retroactive' Tax Credits as Latest HIX Triage

For state exchanges still struggling to function, and governors facing the consequences, the Centers for Medicare & Medicaid Services is offering an exception to the rule of tax credits only being available through public marketplaces.
Published Online: March 05, 2014
For state exchanges still struggling to function, and governors facing the consequences, the Centers for Medicare & Medicaid Services is offering an exception to the rule of tax credits only being available through public marketplaces.

State exchanges that “have had difficulty in providing timely eligibility determinations to applicants and enrolling qualified individuals” now have several last-minute options to offer consumers advanced premium tax credits.

In a new bulletin from CMS’s Center for Consumer Information and Insurance Oversight, regulators wrote that insurance exchanges with such “exceptional circumstances” — including, presumably, those operated by Healthcare.gov — can make premium tax credits and cost-sharing reductions available on a retroactive basis, both for policies purchased (or in the process of being purchased) through public exchanges and those bought through private exchanges, brokers or directly from insurers.

Read the full story here: http://bit.ly/NRPclu

Source: Healthcare Payer News



Feature
Recommended Articles
Research conducted at the Duke University School of Medicine indicates triple therapy may increase risk of bleeding in geriatric patients with myocardial infarction who have a stent.
Troy Trygstad, PharmD, MBA, PhD, vice president of pharmacy programs at Community Care of North Carolina, expressed the importance of a healthcare approach that concentrates on patient care and various delivery models that, in the end, promote long-term health and changes in health trajectory.
In the fourth year of the Hospital Readmissions Reduction Program, which makes hospitals pay closer attention to their patients after discharge, half of the nation’s hospitals will be penalized by Medicare because of their readmissions.
A research team at the Barts Cancer Institute in London has identified a 3-protein molecular signature in pancreatic cancer patients.
A study attempting to characterize the true preventability of venous thromboembolism determined that financial penalties based on the total number of patients who suffer blood clots in the lung or leg may be unfairly imposed.